JENNIFER VANCE: Open Payments
NPI 1316183429 · STERLING, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,258 in 121 payments from 21 companies in 2025. Trend: 2023 $1,679 · 2024 $1,734 · 2025 $2,258
Food & beverage: $2,258
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 16 | $297 |
| PFIZER INC. | 16 | $268 |
| AstraZeneca Pharmaceuticals LP | 11 | $231 |
| GlaxoSmithKline, LLC. | 14 | $190 |
| Astellas Pharma US Inc | 8 | $172 |
| Amgen Inc. | 10 | $166 |
| Axsome Therapeutics, Inc. | 7 | $142 |
| ABBVIE INC. | 6 | $110 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $90 |
| Merck Sharp & Dohme LLC | 3 | $72 |
Products named: TRELEGY ELLIPTA, Veozah, Auvelity, AIRSUPRA, ELIQUIS, VRAYLAR, Ozempic, NURTEC ODT.
Industry payments across IL — which companies pay providers there.
